Hallelujah! Please, would someone else confirm this?
If
Hallelujah! Please, would someone else confirm this?
If an off patent drug (bevacizumab/Avastin) that has already been approved for an indication (MSS mCRC) is combined with an unapproved drug (leronlimab) in a Phase II trial (the proposed MSS mCRC clinical trial priority #1) that is identical to the original trial that won the approval of the off patent drug (bevacizumab), and at the end of that combination Phase II trial (CytoDyn's priority #1), its results were successful and met the clinical significance to causing the FDA to give the go ahead for a Phase III trial (in the future commencing say a year from now 9/2025) using the same combination of off patent and unapproved drugs. Then, after the completion of the Phase III trial, clinical significance was again achieved and after the BLA was submitted, the FDA approved the drug combination for that indication.
The question is, can the original off patent drug (bevacizumab) re-apply for patent in this combination treatment with leronlimab for this MSS mCRC indication and will that new patent again protect that newly patented drug Avastin + leronlimab for another 12 years?
Also, if you can supply any examples.
Thank you so much.
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
PSE&G Climbs To Number One Spot: What's Changed? Public Service Electric & Gas (PSE&G), New Jersey's largest utility, just snagged the top spot for business electric customer satisfaction in the East, according to JD Power's latest study. This is an upgrade from their second place showing in 2025. But how did they leapfrog their competition to reach the pinnacle? The...
Continue Reading
Decibel Sets Sail on the OTCQX Best Market Right off the bat, we're talking about Decibel Cannabis Company Inc. making waves by jumping from the OTCQB to the more reputable OTCQX Best Market. If this doesn’t make you sit up and take notice, I don’t know what will. The ticker OTCQX:DBCCF is now on a stage where it can potentially woo more U.S. investors, and given the...
Continue Reading
NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...
Continue Reading
A Personal Mission Driving Business in Hollywood Dive deep into any community, and you'll often find stories that tug at the heartstrings—especially when they're about family. That's the case with Saudia Sital, a Broward County local who's just opened Always Best Care Senior Services in Hollywood, Florida. Her journey from personal caregiver to business owner isn't just...
Continue Reading
Investor Blues: Fluence Under the Weather If you've been keeping an eye on Fluence Energy (NASDAQ:FLNC), you're probably clutching your metaphorical pearls right now. Here's the scoop: on November 2, 2026, the stock took another nosedive—dropping nearly 9%—as the company announced that both CEO Julian Nebreda and CFO Ahmad Pasha had packed their bags. A leadership...
Continue Reading
Eve Air Mobility's Vector system just pulled off something impressive at the Interlagos Circuit, showing it's not just a buzzword in the urban air mobility sphere. Picture this—over 100 helicopter flights in a day, all managed smoothly during one of the biggest motorsport events. That's the kind of action that gets investors to sit up and take notice of NYSE:EVEX....
Continue Reading
Navigating the Dance Style Maze Picking a dance style is no joke, especially when every option seems to spin its own tale. It ain't just about twirling to your favorite rhythm. There's a whole spectrum of styles, from graceful ballet to punchy hip-hop, each with its ticklish quirks and temptations. Sandy Young and Jenna Engen, dance experts from Young Dance Academy Inc....
Continue Reading
Diving into the World of Pressure-Treated Lumber John Michael Nixa, the go-to expert from West Side Lumber, has dropped some real nuggets in the world of pressure-treated lumber. This isn't some clickbait headline; it's about making sure your deck or fence doesn't fall apart after the first thunderstorm. Understanding the Lumber Treatment Now, before you run off to the...
Continue Reading
Revving up efficiency in healthcare usually sounds like pie-in-the-sky talk, but every now and again, an innovation comes along that really stirs the pot. Enter Dyania Health's Synapsis AI, a clinical reasoning AI, teaming with NVIDIA's robust computing infrastructure. They're setting out to make sense of massive amounts of patient data, securely tucked behind a...
Continue Reading
When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...
Continue Reading
Top 5 Most Recently Viewed Articles
Visage Introduces Innovations in AI Enhanced Imaging Visage Imaging, Inc. is set to unveil several cutting-edge advancements at the upcoming RSNA 2025 annual meeting. Known for their industry-leading Visage 7 | CloudPACS, the company aims to enhance enterprise imaging with powerful AI tools designed specifically for today's demands in the healthcare sector. Understanding...
Continue Reading
Madison Liquidators Expands Office Solutions with Floortex Mats Madison Liquidators has made exciting additions to their office furniture lineup by introducing new office chair mats from the well-regarded brand partner, Floortex. These mats play a vital role in enhancing the user experience within various workspaces. Designed to protect flooring while supporting ergonomic...
Continue Reading
When you're running a business, sometimes you've got to cut off a leg to save the rest. And that's just what Clarivate's done, shoveling their Life Sciences & Healthcare segment off to Altaris LLC for a cool $600 million. Now, this ain't just to jazz up the books—it's about reshaping the future. They're slicing and dicing to laser-beam their focus on Academia &...
Continue Reading
Alecta Transitions to FlexTRADER EMS for Enhanced Trading Alecta, one of Europe’s largest occupational pension companies, has recently optimized its cross-asset trading by adopting FlexTRADER EMS, a powerful execution management system provided by FlexTrade Systems. This new system is designed specifically to enhance Alecta's capabilities in equities and derivatives...
Continue Reading
Crescent Capital Group's Role in Financing Crescent Capital Group LP, a prominent name in alternative credit investment, has recently taken a significant step by leading the financing for the acquisition of Independent Governance Group (IGG). This acquisition is a joint venture with ECI Partners, a mid-market private equity firm based in the UK. The partnership aims to...
Continue Reading